Hepatocellular Carcinoma Global Clinical Trials Review, H1, 2012

Hepatocellular Carcinoma Global Clinical Trials Review, H1, 2012

Summary

GlobalData's clinical trial report, “Hepatocellular Carcinoma Global Clinical Trials Review, H2, 2011" provides data on the Hepatocellular Carcinoma clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Hepatocellular Carcinoma. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Hepatocellular Carcinoma. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

• Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
• Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
• Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

• Understand the dynamics of a particular indication in a condensed manner
• Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
• Obtain discontinued trial listing for trials across the globe
• Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Contents

Table of Contents
List of Tables
List of Figures
Introduction
Hepatocellular Carcinoma
Report Guidance
Clinical Trials by Region
Clinical Trials by Country
Top Five Countries Contributing to Clinical Trials in Asia-Pacific
Top Five Countries Contributing to Clinical Trials in Europe
Top Countries Contributing to Clinical Trials in North America
Top Five Countries Contributing to Clinical Trials in Middle East and Africa
Top Five Countries Contributing to Clinical Trials in Central and South America
Clinical Trials by BRIC Nations
Clinical Trials by G7 Nations
Clinical Trials in G7 Nations by Trial Status
Clinical Trials by E7 Nations
Clinical Trials in E7 Nations by Trial Status
Clinical Trials by Phase
In Progress Trials by Phase
Clinical Trials by Trial Status
Unaccomplished Trials of Hepatocellular Carcinoma
Subjects Recruited Over a Period of Time
Prominent Sponsors
Top Companies Participating in Hepatocellular Carcinoma Therapeutics Clinical Trials
Prominent Drug Comparison
Clinical Trial Profiles
Clinical Trial Overview of Top Companies
Bayer AG
Clinical Trial Overview of Bayer AG
Bristol-Myers Squibb Company
Clinical Trial Overview of Bristol-Myers Squibb Company
Novartis AG
Clinical Trial Overview of Novartis AG
Sanofi
Clinical Trial Overview of Sanofi
Eli Lilly and Company
Clinical Trial Overview of Eli Lilly and Company
AstraZeneca PLC
Clinical Trial Overview of AstraZeneca PLC
Taiho Pharmaceutical Co., Ltd.
Clinical Trial Overview of Taiho Pharmaceutical Co., Ltd.
Jennerex Biotherapeutics, Inc.
Clinical Trial Overview of Jennerex Biotherapeutics, Inc.
Pfizer Inc.
Clinical Trial Overview of Pfizer Inc.
Eisai Inc.
Clinical Trial Overview of Eisai Inc.
GlaxoSmithKline plc
Clinical Trial Overview of GlaxoSmithKline plc
Abbott Laboratories
Clinical Trial Overview of Abbott Laboratories
Chugai Pharmaceutical Co., Ltd.
Clinical Trial Overview of Chugai Pharmaceutical Co., Ltd.
ArQule, Inc.
Clinical Trial Overview of ArQule, Inc.
Celsion Corporation
Clinical Trial Overview of Celsion Corporation
F. Hoffmann-La Roche Ltd.
Clinical Trial Overview of F. Hoffmann-La Roche Ltd.
Boehringer Ingelheim GmbH
Clinical Trial Overview of Boehringer Ingelheim GmbH
Adherex Technologies Inc.
Clinical Trial Overview of Adherex Technologies Inc.
Amgen Inc.
Clinical Trial Overview of Amgen Inc.
Otsuka Pharmaceutical Co., Ltd.
Clinical Trial Overview of Otsuka Pharmaceutical Co., Ltd.
Clinical Trial Overview of Top Universities / Institutes / Hospitals
Eastern Hepatobiliary Surgery Hospital
Clinical Trial Overview of Eastern Hepatobiliary Surgery Hospital
Sun Yat-sen University
Clinical Trial Overview of Sun Yat-sen University
FUDAN University
Clinical Trial Overview of FUDAN University
Seoul National University Hospital
Clinical Trial Overview of Seoul National University Hospital
Kaohsiung Medical University Chung-Ho Memorial Hospital
Clinical Trial Overview of Kaohsiung Medical University Chung-Ho Memorial Hospital
Assistance Publique - Hopitaux de Paris
Clinical Trial Overview of Assistance Publique - Hopitaux de Paris
University of Milan
Clinical Trial Overview of University of Milan
Massachusetts General Hospital
Clinical Trial Overview of Massachusetts General Hospital
Stanford University
Clinical Trial Overview of Stanford University
Kyoto University
Clinical Trial Overview of Kyoto University
Niigata Hepatocellular Carcinoma Therapy Study Group
Clinical Trial Overview of Niigata Hepatocellular Carcinoma Therapy Study Group
University Health Network
Clinical Trial Overview of University Health Network
University of Pittsburgh
Clinical Trial Overview of University of Pittsburgh
Chinese University of Hong Kong
Clinical Trial Overview of Chinese University of Hong Kong
The University of Tokyo Hospital
Clinical Trial Overview of The University of Tokyo Hospital
Kanazawa Medical University
Clinical Trial Overview of Kanazawa Medical University
Yokohama City University Medical Center
Clinical Trial Overview of Yokohama City University Medical Center
The University of Texas M. D. Anderson Cancer Center
Clinical Trial Overview of The University of Texas M. D. Anderson Cancer Center
All India Institute of Medical Sciences
Clinical Trial Overview of All India Institute of Medical Sciences
Sidney Kimmel Comprehensive Cancer Center
Clinical Trial Overview of Sidney Kimmel Comprehensive Cancer Center
Five Key Clinical Profiles
Appendix
Abbreviations
Definitions
Research Methodology
Secondary Research
About GlobalData
Contact Us
Disclaimer
Source

LIST OF TABLES

Hepatocellular Carcinoma Therapeutics Market, Global, Clinical Trials by Zone, 2012*
Hepatocellular Carcinoma Therapeutics Market, Global, Clinical Trials by Top Countries, 2012*
Hepatocellular Carcinoma Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2012*
Hepatocellular Carcinoma Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2012*
Hepatocellular Carcinoma Therapeutics Clinical Trials, Europe, Top Five Countries, 2012*
Hepatocellular Carcinoma Therapeutics Clinical Trials, North America, Top Countries, 2012*
Hepatocellular Carcinoma Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2012*
Hepatocellular Carcinoma Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2012*
Hepatocellular Carcinoma Therapeutics Clinical Trials, BRIC Countries, 2012*
Hepatocellular Carcinoma Therapeutics Clinical Trials, G7 Countries, 2012*
Hepatocellular Carcinoma Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2012*
Hepatocellular Carcinoma Therapeutics Clinical Trials, E7 Countries, 2012*
Hepatocellular Carcinoma Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2012*
Hepatocellular Carcinoma Therapeutics Market, Global, Clinical Trials by Phase, 2012*
Hepatocellular Carcinoma Therapeutics Market, Global, Clinical Trials In Progress by Phase 2012*
Hepatocellular Carcinoma Therapeutics Market, Global, Clinical Trials by Trial Status, 2012*
Hepatocellular Carcinoma Therapeutics Market, Global, Suspended Clinical Trials, 2012*
Hepatocellular Carcinoma Therapeutics Market, Global, Withdrawn Clinical Trials, 2012*
Hepatocellular Carcinoma Therapeutics Market, Global, Terminated Clinical Trials, 2012*
Hepatocellular Carcinoma Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2005-2010
Hepatocellular Carcinoma Therapeutics Clinical Trials, Global, Key Sponsors, 2012*
Hepatocellular Carcinoma Therapeutics Clinical Trials, Global, Top Companies by Phase, 2012*
Hepatocellular Carcinoma Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2012*
Hepatocellular Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Bayer AG, 2012*
Hepatocellular Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Bristol-Myers Squibb Company, 2012*
Hepatocellular Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2012*
Hepatocellular Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Sanofi, 2012*
Hepatocellular Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Eli Lilly and Company, 2012*
Hepatocellular Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by AstraZeneca PLC, 2012*
Hepatocellular Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Taiho Pharmaceutical Co., Ltd., 2012*
Hepatocellular Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Jennerex Biotherapeutics, Inc., 2012*
Hepatocellular Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2012*
Hepatocellular Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Eisai Inc., 2012*
Hepatocellular Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2012*
Hepatocellular Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Abbott Laboratories, 2012*
Hepatocellular Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Chugai Pharmaceutical Co., Ltd., 2012*
Hepatocellular Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by ArQule, Inc., 2012*
Hepatocellular Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Celsion Corporation, 2012*
Hepatocellular Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by F. Hoffmann-La Roche Ltd., 2012*
Hepatocellular Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Boehringer Ingelheim GmbH, 2012*
Hepatocellular Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Adherex Technologies Inc., 2012*
Hepatocellular Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Amgen Inc., 2012*
Hepatocellular Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Otsuka Pharmaceutical Co., Ltd., 2012*
Hepatocellular Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Eastern Hepatobiliary Surgery Hospital, 2012*
Hepatocellular Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Sun Yat-sen University, 2012*
Hepatocellular Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by FUDAN University, 2012*
Hepatocellular Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Seoul National University Hospital, 2012*
Hepatocellular Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Kaohsiung Medical University Chung-Ho Memorial Hospital, 2012*
Hepatocellular Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Assistance Publique - Hopitaux de Paris, 2012*
Hepatocellular Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Milan, 2012*
Hepatocellular Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Massachusetts General Hospital, 2012*
Hepatocellular Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Stanford University, 2012*
Hepatocellular Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Kyoto University, 2012*
Hepatocellular Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Niigata Hepatocellular Carcinoma Therapy Study Group, 2012*
Hepatocellular Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by University Health Network, 2012*
Hepatocellular Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Pittsburgh, 2012*
Hepatocellular Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Chinese University of Hong Kong, 2012*
Hepatocellular Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Tokyo Hospital, 2012*
Hepatocellular Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Kanazawa Medical University, 2012*
Hepatocellular Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Yokohama City University Medical Center, 2012*
Hepatocellular Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Texas M. D. Anderson Cancer Center, 2012*
Hepatocellular Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by All India Institute of Medical Sciences, 2012*
Hepatocellular Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Sidney Kimmel Comprehensive Cancer Center, 2012*

LIST OF FIGURES

Hepatocellular Carcinoma Therapeutics Market, Global, Clinical Trials by Zone (%), 2012*
Hepatocellular Carcinoma Therapeutics Market, Global, Clinical Trials by Top Countries, 2012*
Hepatocellular Carcinoma Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2012*
Hepatocellular Carcinoma Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2012*
Hepatocellular Carcinoma Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2012*
Hepatocellular Carcinoma Therapeutics Clinical Trials, North America, Top Countries (%), 2012*
Hepatocellular Carcinoma Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2012*
Hepatocellular Carcinoma Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2012*
Hepatocellular Carcinoma Therapeutics Clinical Trials, BRIC Countries (%), 2012*
Hepatocellular Carcinoma Therapeutics Clinical Trials, G7 Countries (%), 2012*
Hepatocellular Carcinoma Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2012*
Hepatocellular Carcinoma Therapeutics Clinical Trials, E7 Countries (%), 2012*
Hepatocellular Carcinoma Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2012*
Hepatocellular Carcinoma Therapeutics Market, Global, Clinical Trials by Phase (%), 2012*
Hepatocellular Carcinoma Therapeutics Market, Global, Clinical Trials In Progress by Phase, 2012*
Hepatocellular Carcinoma Therapeutics Market, Global, Clinical Trials by Trial Status, 2012*
Hepatocellular Carcinoma Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2005-2010
Hepatocellular Carcinoma Therapeutics Clinical Trials, Global, Key Sponsors, 2012*
Hepatocellular Carcinoma Therapeutics Clinical Trials, Global, Top Companies by Phase, 2012*
Hepatocellular Carcinoma Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2012*
GlobalData Methodology Skip to top